Revolution Medicines Inc (RVMD) — Financial Flexibility Index
Revolution Medicines Inc (RVMD) has a Financial Flexibility Index of -0.31x as of September 2025. Free cash flow of $-203.96 Million (operating CF $-207.31 Million minus capex $3.35 Million) represents 0% of total liabilities ($655.02 Million). Also explore how fast is Revolution Medicines Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Revolution Medicines Inc Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for Revolution Medicines Inc across 8 annual periods. Check asset allocation strategy of Revolution Medicines Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Revolution Medicines Inc (2017–2024)
Year-by-year free cash flow to debt coverage for Revolution Medicines Inc. For the full company profile including market capitalisation, see how much is Revolution Medicines Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.87x | $-547.13 Million | $-557.44 Million | $293.10 Million | ▼ -28.2% |
| 2023 | -1.46x | $-342.84 Million | $-350.57 Million | $235.51 Million | ▲ +13.6% |
| 2022 | -1.69x | $-213.59 Million | $-224.40 Million | $126.74 Million | ▼ -62.3% |
| 2021 | -1.04x | $-140.65 Million | $-147.18 Million | $135.42 Million | ▲ +0.8% |
| 2020 | -1.05x | $-97.13 Million | $-100.06 Million | $92.72 Million | ▼ -51.5% |
| 2019 | -0.69x | $-47.03 Million | $-49.62 Million | $67.99 Million | ▼ -1985.3% |
| 2018 | 0.04x | $2.71 Million | $1.21 Million | $73.93 Million | ▲ +101.6% |
| 2017 | -2.24x | $-23.57 Million | $-25.15 Million | $10.55 Million | — |